Back
Madrigal Pharmaceuticals 10K Form
Sell
46
MDGL
Madrigal Pharmaceuticals
Last Price:
$291.14
Seasonality Move:
-7.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDGL News And Ratings
See the #1 stock for the next 7 days that we like better than MDGL
MDGL Financial Statistics
Sales & Book Value
| Annual Sales: | $180.1M |
|---|---|
| Cash Flow: | $-88.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $32.03 |
| Price / Book: | 9.09 |
Profitability
| EPS (TTM): | -18.05000 |
|---|---|
| Net Income (TTM): | $-391.6M |
| Gross Margin: | $173.9M |
| Return on Equity: | -49.57% |
| Return on Assets: | -36.98% |
Madrigal Pharmaceuticals Earnings Forecast
Key Madrigal Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 8 years for MDGL is 96.54%.
-
The Selling, General & Administrative Expenses for MDGL have been equal to 241.52% of Gross Profit Margin.
-
The Research & Development expenses have been 131.41% of Revenue.
-
The Net Earning history of MDGL is -258.64% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 8 years.
Madrigal Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDGL |
| CUSIP: | 558868 |
| Website: | madrigalpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 5.91 |
| Quick Ratio: | 5.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 1391.82 |
MDGL Technical Analysis vs Fundamental Analysis
Sell
46
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a SellThe current Madrigal Pharmaceuticals [MDGL] share price is $290.96. The Score for MDGL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.